Ó¤Ó׶ùѪ¹ÜÁöµÄÕïÖνøÕ¹

²Î¿¼ÎÄÏ×/References:

1Mulliken JB,Glowacki J.Hemangiomas and vascular malformatª²ions in infants and children: a classification based on endotª²helial characteristics\[J\].Plast Reconstr Surg, 1982, 69(3):412¡ª422.
2Hidano A,Nakajima S.Earliest features of the strawberry mark in the newborn\[J\].Br J Dermatol,1972,87(2):138¡ª144.
3Haggstrom AN,Drolet BA,Baselga E,et al.Prospective study of infantile hemangiomas: demographic,prenatal,and perinatal characteristics\[J\].J Pediatr,2007,150(3):291¡ª294.
4Mulliken JB,Fishman SJ,Burrows PE.Vascular anomalies\[J\].In:Wells SA,Creswell LL, eds.Vascular Anomalies.St Louis,MO:Mosby,2000,37(8):517¡ª584.
5Mulliken JB,Glowacki J.Hemangiomas and vascular malformations ininfants and Children:a classif ication based on endothelial characteristics\[J\].Plast Reconstr Surg,1982,69(3):412¡ª412.
6Chiller KG,Passaro D,Frieden IF.Hemangiomas of infancy:clinical characteristics,morphologic subtypes,and their relationship to race,ethnicity,and sex\[J\].Arch Dermatol,2002,138(12):1567¡ª1576.
7Finn MC,Glowacki J,Mulliken JB.Congenital vascular lesions:clinical application of a new classification\[J\].J Pediatr Surg,1983,18(6):894¡ª900.
8ÕÅÖ¾Ô¸£¬ÕÔâù·¼.Í·¾±²¿Ñª¹ÜÁöÓëѪ¹Ü»ûÐÎ\[M\].ÉϺ££ºÉϺ£ÊÀ½çͼÊé³ö°æ¹«Ë¾£¬2007:77¡ª78.
9Zhang L,Lin XX,Qi ZL,et al.Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation\[J\].Zhonghua Wai Ke Za Zhi,2006,44(3):186¡ª188.
10Zhang L,Lin X,Wang W,et al.Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients\[J\].Plast Reconstr Surg, 2005,116(1):200¡ª204.
11Boon LM,Bataille AC,BemierV,et al.Medical treatment of juvenile hemangiomas\[J\].Ann Chir Plast Esthet,2006,51(4-5):310¡ª320.
12Ebrahem Q,Minamoto A,Hoppe G,et al.Triamcinolone acetonide inhibits IL¡ª6¡ªand VEGFª²induced angiogenesis downstream of the IL¡ª6 and VEGF receptors\[J\].Invest Ophthalmol Vis Sci, 2006, 47(11):4935¡ª4941.
13Rossler J,Wehl G,Niemeyer CM.Evaluating systemic prednisone therapy for proliferating haemangioma in infancy\[J\].Eur J Pediatr,2008,167(7):813¡ª815.
14George ME,Sharma V,Jacobson J,et al.Adverse effects of systemic glucocorticosteroid therapy in infants with hemangiomas\[J\].Arch Dermatol,2004, 140(8):963¡ª969.
15Lomenick JP,Reifschneider KL,Lucky AW,et al.Prevalence of adrenal insufficiency following systemic glucocorticoid therapy in infants with hemangiomas\[J\].Arch Dermatol., 2009, 145(3):262¡ª266.
16Michaud AP,Bauman NM,Burke DK,Manaligod JM,Smith RJ.Spastic diplegia and other motor disturbances in infants receiving interferon-alpha\[J\].Laryngoscope.2004,114(7):1231¡ª1236.